Schrohl, Anne-Sofie <br/><br/>
Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study.  [electronic resource] 

 -  BMC cancer  Sep 2009 
 - 322 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-9-322  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anthracyclines--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cohort Studies<br/>Cyclophosphamide--therapeutic use<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Lymphatic Metastasis<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Premenopause<br/>Retrospective Studies<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Treatment Outcome